Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Through comprehensive experimental and clinical research, PCD may be used as a target for the development of therapeutic medications that tackle the underlying causes of OA without adverse effects or consequences
It binds the GHRH receptor (GHRHR) on pituitary somatotrophs, activating adenylyl cyclase and increasing intracellular cAMP
HOURS Mon - Fri: 8:00 am - 5:30 pm Sat - Sun: Closed CONTACT Phone: 847-827-5200 Email: [email protected]
10.1007/s13311-014-0329-3 Neurotherapeutics 198 HouY.LautrupS.CordonnierS.WangY.CroteauD
US$ 27.78
US$ 24.10
US$ 25.08
US$ 20.66
